Literature DB >> 19791746

Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.

Michal Vieth1, Jon Erickson, Jibo Wang, Yue Webster, Mary Mader, Richard Higgs, Ian Watson.   

Abstract

A reconstructive approach based on computational fragmentation of existing inhibitors and validated kinase potency models to recombine and create "de novo" kinase inhibitor small molecule libraries is described. The screening results from model selected molecules from the corporate database and seven computationally derived small molecule libraries were used to evaluate this approach. Specifically, 1895 model selected database molecules were screened at 20 microM in six kinase assays and yielded an overall hit rate of 84%. These models were then used in the de novo design of seven chemical libraries consisting of 20-50 compounds each. Then 179 compounds from synthesized libraries were tested against these six kinases with an overall hit rate of 92%. Comparing predicted and observed selectivity profiles serves to highlight the strengths and limitations of the methodology, while analysis of functional group contributions from the libraries suggest general principles governing binding of ATP competitive compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19791746     DOI: 10.1021/jm901147e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Computational Modeling of Kinase Inhibitor Selectivity.

Authors:  Govindan Subramanian; Manish Sud
Journal:  ACS Med Chem Lett       Date:  2010-07-28       Impact factor: 4.345

2.  The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.

Authors:  Xiao-Feng Le; Weiqun Mao; Guangan He; Francois-Xavier Claret; Weiya Xia; Ahmed Ashour Ahmed; Mien-Chie Hung; Zahid H Siddik; Robert C Bast
Journal:  J Natl Cancer Inst       Date:  2011-08-02       Impact factor: 13.506

3.  Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.

Authors:  Amanda J DeGraw; Michael J Keiser; Joshua D Ochocki; Brian K Shoichet; Mark D Distefano
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

4.  Creating a Virtual Assistant for Medicinal Chemistry.

Authors:  Lewis R Vidler; Matthew P Baumgartner
Journal:  ACS Med Chem Lett       Date:  2019-06-07       Impact factor: 4.345

5.  Idea2Data: Toward a New Paradigm for Drug Discovery.

Authors:  Christos A Nicolaou; Christine Humblet; Hong Hu; Eva M Martin; Frank C Dorsey; Thomas M Castle; Keith Ian Burton; Haitao Hu; Jorg Hendle; Michael J Hickey; Joel Duerksen; Jibo Wang; Jon A Erickson
Journal:  ACS Med Chem Lett       Date:  2019-02-04       Impact factor: 4.345

Review 6.  Enhanced interrogation: emerging strategies for cell signaling inhibition.

Authors:  Rong Huang; Isabel Martinez-Ferrando; Philip A Cole
Journal:  Nat Struct Mol Biol       Date:  2010-06       Impact factor: 15.369

7.  Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.

Authors:  Julio Caballero; Miguel Quiliano; Jans H Alzate-Morales; Mirko Zimic; Eric Deharo
Journal:  J Comput Aided Mol Des       Date:  2011-04-13       Impact factor: 3.686

8.  Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors.

Authors:  Eman M Dokla; Amr H Mahmoud; Mohamed S A Elsayed; Ahmed H El-Khatib; Michael W Linscheid; Khaled A Abouzid
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

9.  De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.

Authors:  Robert Urich; Grant Wishart; Michael Kiczun; André Richters; Naomi Tidten-Luksch; Daniel Rauh; Brad Sherborne; Paul G Wyatt; Ruth Brenk
Journal:  ACS Chem Biol       Date:  2013-03-27       Impact factor: 5.100

10.  A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis.

Authors:  Anuradha Kumar; Allen Casey; Joshua Odingo; Edward A Kesicki; Garth Abrahams; Michal Vieth; Thierry Masquelin; Valerie Mizrahi; Philip A Hipskind; David R Sherman; Tanya Parish
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.